Display Settings:

Format

Send to:

Choose Destination

    Mayo Clin Proc. 2003 Jul;78(7):830-5.

    Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

    Arora AS, Perrault J, Smyrk TC.

    Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA. arora.amindra@mayo.edu

    OBJECTIVE: To describe the clinical features of patients with eosinophilic esophagitis and the use of topical corticosteroids for treatment. PATIENTS AND METHODS: We evaluated the charts of 21 patients with a diagnosis of eosinophilic esophagitis seen at the Mayo Clinic in Rochester, Minn, between September 1, 1999, and December 31, 2001. The diagnosis was based on the presence of a "ringed esophagus" or a tapered distal esophagus on upper endoscopy as well as the presence of a dense eosinophilic infiltrate on esophageal biopsy. All patients were treated with topical corticosteroids, and follow-up was performed by telephone interviews. RESULTS: The 17 men and 4 women ranged in age from 28 years to 55 years at diagnosis (mean, 40 years). All had solid-food dysphagia for at least 6 years, and 15 patients had prior food impaction. Eighteen patients had either a ringed-appearing esophagus or smooth tapering in the distal esophagus. All patients had a dense eosinophilic infiltration (> 20 eosinophils per high-power field) in the mid or distal esophagus. Topical corticosteroid therapy for 6 weeks resulted in complete dysphagia relief in all patients and lasted a minimum of 4 months. CONCLUSION: Eosinophilic esophagitis is an entity associated with food dysphagia (predominantly in young adults) and a ringed or smooth tapered distal-appearing esophagus. Our study found no association with gastroesophageal reflux symptoms. Topical corticosteroid therapy was effective.

    PMID: 12839078 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read Click here to read